<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00824109</url>
  </required_header>
  <id_info>
    <org_study_id>HR07-001</org_study_id>
    <nct_id>NCT00824109</nct_id>
  </id_info>
  <brief_title>Prospective, Multicenter Study of the Second Generation Antimicrobial Graft in the Abdominal Position</brief_title>
  <official_title>Multicenter Clinical Study Assessing the Performance and the Safety of the Second Generation Antimicrobial Graft in the Abdominal Position</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Datascope Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Datascope Corp.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this prospective trial is to demonstrate the safety and performance of the
      Second Generation Anti-Microbial vascular graft in the treatment of aneurysmal and occlusive
      diseases of the abdominal aorta.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2008</start_date>
  <completion_date type="Anticipated">September 2011</completion_date>
  <primary_completion_date type="Anticipated">September 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Graft patency at three years</measure>
    <time_frame>three years</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Aneurysmal Disease of the Abdominal Aorta</condition>
  <condition>Occlusive Disease of the Abdominal Aorta</condition>
  <arm_group>
    <arm_group_label>Single Arm Study</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Consecutive patients meeting the selection criteria</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Second Generation Anti-Microbial bifurcated vascular graft (InterGard)</intervention_name>
    <description>treatment of patients with aorto-iliac occlusion,stenosis, or aneurysm</description>
    <arm_group_label>Single Arm Study</arm_group_label>
    <other_name>InterGard</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Is 18 - 85 years of age

          -  Is presenting with an aorto-iliac occlusion (obstruction of flow) or stenosis, or
             aorto-iliac aneurysm and is eligible for a revascularization with a bifurcated graft

          -  Is affiliated with a social welfare organization system

          -  Is willing to participate in the clinical evaluation after signature of the informed
             consent

          -  Is able to attend all follow up visits and diagnostics and laboratory exams required
             by the present protocol

        Exclusion Criteria:

          -  Is treated as an emergency

          -  Is included in another investigation

          -  Is pregnant or lactating, or a woman of childbearing potential unwillint to use an
             effective form of contraception for the duration of the trial

          -  Has a known allergy to the material device used

          -  Has previous aorto-iliac bypass or replacement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Baptiste Ricco, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vascular Surgery Dept, CHU La Miletrie</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Baptiste Ricco, MD, Professor</last_name>
    <phone>00 33 5494438 46</phone>
    <email>j.b.ricco@chu-poitiers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Philippe Bensimon, Director</last_name>
    <phone>011 33 44 208 7784</phone>
    <email>philippe.bensimon@datascope.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU La Miletrie, 350 av. Jacques Coeur</name>
      <address>
        <city>86021 Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Baptiste Ricco, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2009</study_first_submitted>
  <study_first_submitted_qc>January 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2009</study_first_posted>
  <last_update_submitted>December 2, 2010</last_update_submitted>
  <last_update_submitted_qc>December 2, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2010</last_update_posted>
  <responsible_party>
    <name_title>Philippe Bensimon, Director, Regulatory and Clinical Affairs, and Quality Assurance</name_title>
    <organization>Datascope InterVascular</organization>
  </responsible_party>
  <keyword>Aneurysmal disease of the abdominal aorta</keyword>
  <keyword>Occlusive disease of the abdominal aorta</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Infective Agents</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

